• Info
  • Insider Trading

Insider Transactions Reported by 14 Insiders of Entasis Therapeutics Holdings Inc.

Location
Waltham, MA

There are no Buy or Sell transactions made by insiders since 13 Mar 2025

Entasis Therapeutics Holdings Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Innoviva, Inc. 10%+ Owner $162,821,214 08 Jul 2022
Michael Gutch Chief Financial Officer and Chief Business Officer 18 Jan 2022
DAVID C. HASTINGS Director 07 Jul 2022
Anna Diaz Triola Chief Commercial Officer 11 Jul 2022
Matthew Ronsheim Chief of Pharma Sciences & MFG 07 Jul 2022
Ruben Tommasi Chief Scientific Officer 07 Jul 2022
Manoussos Perros President and CEO, Director 07 Jul 2022
Kristie Ann Wagner VP, Principal Fin & Acct Off 11 Jul 2022
David D. Meek Director 07 Jul 2022
Elizabeth M. Keiley General Counsel 07 Jul 2022
Howard Mayer Director 07 Jul 2022
David Altarac Chief Medical Officer 07 Jul 2022
John Patrick Mueller Chief Development Officer 07 Jul 2022
Heather A. Berger Director 07 Jul 2022

Recent Insider Transactions by Companies or Individuals for Entasis Therapeutics Holdings Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Kristie Ann Wagner Common Stock Disposed to Issuer -100% -80,500 0 11 Jul 2022 Direct
Kristie Ann Wagner Stock Option (right to buy) Other -100% -73,400 0 11 Jul 2022 Direct
Anna Diaz Triola Common Stock Disposed to Issuer -100% -125,000 0 11 Jul 2022 Direct
Anna Diaz Triola Stock Option (right to buy) Other -100% -100,000 0 11 Jul 2022 Direct
Ruben Tommasi Common Stock Disposed to Issuer -100% -150,000 0 11 Jul 2022 Direct
Ruben Tommasi Stock Option (right to buy) Other -100% -180,023 0 11 Jul 2022 Direct
Matthew Ronsheim Common Stock Disposed to Issuer -100% -150,000 0 11 Jul 2022 Direct
Matthew Ronsheim Stock Option (right to buy) Other -100% -88,333 0 11 Jul 2022 Direct
Manoussos Perros Common Stock Disposed to Issuer -100% -478,500 0 11 Jul 2022 Direct
Manoussos Perros Stock Option (right to buy) Other -100% -723,738 0 11 Jul 2022 Direct
John Patrick Mueller Common Stock Disposed to Issuer -100% -150,000 0 11 Jul 2022 Direct
John Patrick Mueller Stock Option (right to buy) Other -100% -169,043 0 11 Jul 2022 Direct
Heather A. Berger Common Stock Disposed to Issuer -100% -27,500 0 11 Jul 2022 Direct
Heather A. Berger Stock Option (right to buy) Other -100% -28,307 0 11 Jul 2022 Direct
David Altarac Common Stock Disposed to Issuer -100% -150,000 0 11 Jul 2022 Direct
David Altarac Stock Option (right to buy) Other -100% -142,307 0 11 Jul 2022 Direct
Howard Mayer Common Stock Disposed to Issuer -100% -27,500 0 11 Jul 2022 Direct
Howard Mayer Stock Option (right to buy) Other -100% -23,500 0 11 Jul 2022 Direct
Elizabeth M. Keiley Common Stock Disposed to Issuer -100% -150,000 0 11 Jul 2022 Direct
Elizabeth M. Keiley Stock Option (right to buy) Other -100% -70,833 0 11 Jul 2022 Direct
David D. Meek Common Stock Disposed to Issuer -100% -27,500 0 11 Jul 2022 Direct
David D. Meek Stock Option (right to buy) Other -100% -28,307 0 11 Jul 2022 Direct
DAVID C. HASTINGS Common Stock Disposed to Issuer -100% -27,500 0 11 Jul 2022 Direct
DAVID C. HASTINGS Stock Option (right to buy) Other -100% -37,583 0 11 Jul 2022 Direct
Innoviva, Inc. Common Stock Purchase 35.1% $16,717,391 $2.20 7,598,814 29,270,476 11 Jul 2022 See footnote
Innoviva, Inc. Common Stock Purchase 116.7% $25,677,656 $2.20 11,671,662 21,671,662 08 Jul 2022 See footnote
Ruben Tommasi Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -39,596 0 07 Jul 2022 Direct
Matthew Ronsheim Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -17,572 0 07 Jul 2022 Direct
Manoussos Perros Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -56,072 0 07 Jul 2022 Direct
John Patrick Mueller Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -17,092 0 07 Jul 2022 Direct
Heather A. Berger Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -22,000 0 07 Jul 2022 Direct
David Altarac Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -17,572 0 07 Jul 2022 Direct
Howard Mayer Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -22,000 0 07 Jul 2022 Direct
Elizabeth M. Keiley Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -17,572 0 07 Jul 2022 Direct
David D. Meek Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -22,000 0 07 Jul 2022 Direct
DAVID C. HASTINGS Common Stock Disposition pursuant to a tender of shares in a change of control transaction -100% -22,000 0 07 Jul 2022 Direct
Kristie Ann Wagner Common Stock Award 14.2% 10,000 80,500 24 Feb 2022 Direct
Innoviva, Inc. Warrants to Purchase Common Stock Other 0 10,000,000 18 Feb 2022 See footnotes
Innoviva, Inc. Convertible Promissory Note Other 0 0 18 Feb 2022 See footnote
Ruben Tommasi Common Stock Award 193.5% 125,000 189,596 18 Jan 2022 Direct
Matthew Ronsheim Common Stock Award 293.6% 125,000 167,572 18 Jan 2022 Direct
Manoussos Perros Common Stock Award 30.5% 125,000 534,572 18 Jan 2022 Direct
John Patrick Mueller Common Stock Award 297% 125,000 167,092 18 Jan 2022 Direct
Heather Behanna Common Stock Award 125% 27,500 49,500 18 Jan 2022 Direct
David Altarac Common Stock Award 293.6% 125,000 167,572 18 Jan 2022 Direct
Anna Diaz Triola Common Stock Award 125,000 125,000 18 Jan 2022 Direct
Howard Mayer Common Stock Award 125% 27,500 49,500 18 Jan 2022 Direct
Michael Gutch Common Stock Award 293.6% 125,000 167,572 18 Jan 2022 Direct
Elizabeth M. Keiley Common Stock Award 293.6% 125,000 167,572 18 Jan 2022 Direct
David D. Meek Common Stock Award 125% 27,500 49,500 18 Jan 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.